Table 2 Treatment and clinical outcomes of the two groups
Variables | DM II group (N = 26) | Non-DM II group (N = 52) | P value |
|---|---|---|---|
Treatment | |||
 AMB + 5FC (n %) | 18 (69.23%) | 41 (78.85%) | 0.351 |
 Lip AMB + 5FC (n %) | 5 (19.23%) | 6 (11.54%) | 0.284 |
 AMB + FCZ (n %) | 0 | 3 (5.77%) | 0.212 |
 VCZ ± 5FC (n %) | 3 (11.54%) | 2 (3.84%) | 0.191 |
 Treatment for IICP (n %) | 24 (92.30%) | 47 (90.38%) | 0.779 |
 Repeated LP (n %) | 20 (76.92%) | 39 (75.00%) | 0.852 |
 Temporary drain (n %) | 2 (7.69%) | 5 (9.62%) | 0.779 |
 Permanent shunt device (n %) | 1 (3.85%) | 2 (3.85%) | 1.000 |
 Length of hospitalization (days) | 59.58 ± 29.64 | 42.88 ± 1791 | 0.132 |
 In-hospital mortality | 6 (23.08%) | 4 (7.69%) | 0.055 |